Manufacturing GSK to quit Stevenage for new R&D site in Cambridge PharmaphorumIn a major shake-up of its UK operations, GSK is building a brand new R D centre in Cambridge and transfer operations there from its Stevenage campus.Read full story pharminent July 28, 2026 (Last updated: July 30, 2026) Pharmaphorum In a major shake-up of its UK operations, GSK is building a brand new R D centre in Cambridge and transfer operations there from its Stevenage campus. Read full story Post navigation Previous: Argenx signs agreement to buy Forte Biosciences for $2.2bnNext: Altimmune rises as GLP-1/GIP drug curbs heavy drinking in mid-stage study Related Stories Manufacturing Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision pharminent September 9, 2026 Manufacturing US puts $125m into personalised RNA therapy production pharminent September 2, 2026 Manufacturing Multispecifics are transforming the CDMO development architecture pharminent August 28, 2026